R. Wise

R. Wise, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.

D. Honeybourne, R. Wise, J. Andrews, 1988, Thorax.

In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.

M. Cooper, R. Wise, J. Andrews, 1990, The Journal of antimicrobial chemotherapy.

Pulmonary disposition of antimicrobial agents: methodological considerations

D. Baldwin, D. Honeybourne, R. Wise, 1992, Antimicrobial Agents and Chemotherapy.

Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.

D. Baldwin, D. Honeybourne, R. Wise, 1992, The Journal of antimicrobial chemotherapy.

Quantitative morphology and water distribution of bronchial biopsy samples.

D. Baldwin, D. Honeybourne, R. Wise, 1992, Thorax.

Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.

D. Baldwin, D. Honeybourne, R. Wise, 1993, Respiratory medicine.

Chlamydia pneumoniae and asthma

J. Ayres, W. Tunnicliffe, D. Honeybourne, 1998, Thorax.

Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.

I. Phillips, A. King, D. Reeves, 1991, The Journal of antimicrobial chemotherapy.

Probenecid: an unexplained effect on cephalosporin pharmacology.

P. Welling, M. Kendall, A. Selen, 1979, British journal of clinical pharmacology.

Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project.

G. Lip, D. Beevers, D. Honeybourne, 1998, Stroke.

A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.

R. Wise, J. Andrews, J. Ashby, 1999, The Journal of antimicrobial chemotherapy.

The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

C. Fogarty, R. Wise, J. Andrews, 1998, The Journal of antimicrobial chemotherapy.

Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

J. Andrews, D. Honeybourne, R. Wise, 1999, The Journal of antimicrobial chemotherapy.

Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

J. Andrews, D. Honeybourne, R. Wise, 1999, The Journal of antimicrobial chemotherapy.

Advances in the macrolides and quinolones.

R. Wise, F. Boswell, 1998, Infectious disease clinics of North America.

Pharmacokinetics and Tissue Penetration of Linezolid following Multiple Oral Doses

R. Wise, J. Andrews, J. Ashby, 2001, Antimicrobial Agents and Chemotherapy.

Science, medicine, and the future

Richard Wise, R. Wise, 1998 .

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents.

R. Wise, J. Andrews, F. Boswell, 1995, The Journal of antimicrobial chemotherapy.

QUINOLONE/UREIDOPENICILLIN CROSS-RESISTANCE

L. Piddock, W. Wijnands, R. Wise, 1987, The Lancet.

Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

D. Baldwin, D. Honeybourne, R. Wise, 1992, Antimicrobial Agents and Chemotherapy.

Perspectives on Teicoplanin: Proceedings of a Symposium within the 7th Mediterranean Congress of Chemotherapy, Barcelona, 22 May 1990

R. Wise, 1990 .

In vitro activities of two glycylcyclines

R. Wise, J. Andrews, 1994, Antimicrobial Agents and Chemotherapy.

Letters to the EditorSURGICAL STERILITY

R. Wise, 1973 .

Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.

D. Honeybourne, R. Wise, J. Andrews, 1994, Thorax.

The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory pathogens.

M. Jacobs, G. Schito, F. Goldstein, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Emerging infections--a coordinated European approach.

R. Wise, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chlamydia pneumoniae and acute arterial thrombotic disease.

G. Lip, D. Beevers, D. Honeybourne, 1995, Circulation.

The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.

R. Wise, J. Andrews, J. Woodcock, 1994, The Journal of antimicrobial chemotherapy.

The levels of clarithromycin and its 14-hydroxy metabolite in the lung.

D. Baldwin, D. Honeybourne, R. Wise, 1994, The European respiratory journal.

Properties of the penicillin-binding proteins of four species of the genus Bacteroides

L. Piddock, R. Wise, 1986, Antimicrobial Agents and Chemotherapy.

The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.

D. Honeybourne, R. Wise, J. Andrews, 1999, The Journal of antimicrobial chemotherapy.

Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.

D. Honeybourne, R. Wise, J. Andrews, 1997, The Journal of antimicrobial chemotherapy.

Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.

D. Honeybourne, R. Wise, J. Andrews, 1996, The Journal of antimicrobial chemotherapy.

The penetration of rufloxacin into sites of potential infection in the respiratory tract.

B. Imbimbo, J. Andrews, D. Honeybourne, 1993, The Journal of antimicrobial chemotherapy.

A GUIDE TO SENSITIVITY TESTING

D. Greenwood, R. Wise, J. Andrews, 1991 .

Multidrug-resistant Streptococcus pneumoniae.

R. Wise, C. Catchpole, A. Fraise, 1996, Microbial drug resistance.

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

R. Wise, J. Andrews, N. Brenwald, 1997, The Journal of antimicrobial chemotherapy.

Streptococcus pneumoniae resistance to fluoroquinolones

R. Wise, N. Brenwald, Adam Fraise Martin Gill, 1996, The Lancet.

Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.

D. Baldwin, D. Honeybourne, R. Wise, 1992, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and tissue penetration of ceftibuten

K. Nye, R. Wise, J. Andrews, 1990, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and tissue penetration of cefprozil.

K. Nye, R. Wise, J. Andrews, 1990, The Journal of antimicrobial chemotherapy.

Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

D. Baldwin, D. Honeybourne, R. Wise, 1990, Thorax.

Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers

K. Nye, J. Andrews, G. Douce, 1990, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.

R. Wise, J. Dent, S. Bennett, 1984, The Journal of antimicrobial chemotherapy.

Lung concentrations of telithromycin after oral dosing.

F. Vacheron, D. Honeybourne, R. Wise, 2001, The Journal of antimicrobial chemotherapy.

Bactericidal properties of moxifloxacin and post-antibiotic effect.

A. Dalhoff, R. Wise, J. Andrews, 1999, The Journal of antimicrobial chemotherapy.

Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy.

D. Honeybourne, R. Wise, J. Andrews, 1997, The Journal of antimicrobial chemotherapy.

A Review of the Clinical Pharmacology of Moxifloxacin, a New 8-Methoxyquinolone, and its Potential Relation to Therapeutic Efficacy

R. Wise, 1999 .

Microlavage: a technique for determining the volume of epithelial lining fluid.

D. Baldwin, D. Honeybourne, R. Wise, 1991, Thorax.

Microlavage : a technique for determining the volume of epithelial liningfluid Methods DEVELOPMENT OF PERIPHERAL LAVAGE IN POSTMORTEM LUNGS

D. Baldwin, D. Honeybourne, R. Wise, 2022 .

Concentrations of ceftibuten in plasma and the respiratory tract following a single 400 mg oral dose.

D. Baldwin, D. Honeybourne, R. Wise, 1995, International journal of antimicrobial agents.

The concentration of sparfloxacin in lung tissues after single and multiple oral doses.

D. Baldwin, D. Honeybourne, R. Wise, 1994, International journal of antimicrobial agents.

Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC).

D. Honeybourne, R. Wise, J. Andrews, 1994, FEMS microbiology letters.

The llevels o of c clarithromycin a and iits 1 14-hydroxy m metabolite in tthe llung

D. Baldwin, D. Honeybourne, R. Wise, 1994 .

The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.

D. Baldwin, D. Honeybourne, R. Wise, 1992, The European respiratory journal.

Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin

R. Wise, J. Andrews, J. Child, 1995, Antimicrobial agents and chemotherapy.

The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.

R. Wise, J. Andrews, N. Brenwald, 1993, The Journal of antimicrobial chemotherapy.

The antimicrobial activity of cefpirome, a new cephalosporin.

L. Piddock, R. Wise, J. Andrews, 1985, The Journal of antimicrobial chemotherapy.

Local surveillance of antimicrobial resistance

R. Wise, J. Andrews, 1998, The Lancet.

Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group.

R. Wise, J. Andrews, 1998, Lancet.

In vitro activity of BAY 12-8039, a new fluoroquinolone

R. Wise, J. Andrews, F. Boswell, 1997, Antimicrobial agents and chemotherapy.

The worldwide threat of antimicrobial resistance

R. Wise, 2008 .

A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses.

D. Honeybourne, R. Wise, 1996, The Journal of antimicrobial chemotherapy.

New and future antibiotics in the treatment of acute respiratory tract infections.

R. Wise, 1995, Thorax.

Are glycopeptide-resistant enterococci in animals a threat to human beings?

A. Fraise, I. Das, R. Wise, 1997, The Lancet.

PROVIDENCIA STUARTII INFECTIONS

R. Wise, L. English, C. Keane, 1975, The Lancet.

RAPID DIAGNOSIS OF CAMPYLOBACTER-ASSOCIATED GASTRITIS

C. Mcnulty, R. Wise, 1985, The Lancet.

Chlamydia pneumoniae (TWAR) in neonates.

R. Wise, D. Addy, R. Matthews, 1991, The Pediatric infectious disease journal.

The in-vitro activity of two new quinolones: rufloxacin and MF 961.

R. Wise, J. Andrews, R. Matthews, 1992, The Journal of antimicrobial chemotherapy.

Kanamycin resistance in Povidencia stuartii

R. Wise, L. English, A. Speekenbrink, 1978 .

Maximizing efficacy and reducing the emergence of resistance.

R. Wise, 2003, The Journal of antimicrobial chemotherapy.

In vitro susceptibility of ertapenem by BSAC standardized methodology.

R. Wise, J. Andrews, J. Ashby, 2003, The Journal of antimicrobial chemotherapy.

Detection of ciprofloxacin resistance in Haemophilus influenzae using nalidixic acid and BSAC methodology.

R. Wise, J. Andrews, G. Jevons, 2003, The Journal of antimicrobial chemotherapy.

An outbreak of a CTX-M-type β-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum β-lactamases

P. Hawkey, J. Xiong, R. Wise, 2003 .

Susceptibility testing of Bacillus species.

R. Wise, J. Andrews, 2002, The Journal of antimicrobial chemotherapy.

The 2003 Garrod Lecture The relentless rise of resistance

R. Wise, 2004 .

Epimers of moxalactam: in vitro comparison of activity and stability

P. J. Wills, R. Wise, K. Bedford, 1981, Antimicrobial Agents and Chemotherapy.

In vitro activity of PD 127,391, an enhanced-spectrum quinolone

R. Wise, J. Andrews, J. Ashby, 1988, Antimicrobial Agents and Chemotherapy.

Methicillin-resistant Staphylococcus aureus in the community

A. Fraise, R. Wise, K. Mitchell, 1995, The Lancet.

Making real sense of MRS A

R. Wise, A. Fraise, 1996, The Lancet.

The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.

R. Wise, J. Andrews, D. Thornber, 1991, The Journal of antimicrobial chemotherapy.

The accumulation of five quinolone antibacterial agents by Escherichia coli.

L. Piddock, R. Wise, J. Diver, 1990, The Journal of antimicrobial chemotherapy.

Co-amoxiclav levels in bronchial mucosa.

D. Honeybourne, R. Wise, J. Andrews, 1995, Thorax.

The penetration of cefpirome into the potential sites of pulmonary infection.

D. Baldwin, D. Honeybourne, R. Wise, 1991, The Journal of antimicrobial chemotherapy.

Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and Ceftazidime

H. Simmen, W. Siegenthaler, J. Blaser, 1981, Antimicrobial Agents and Chemotherapy.

Availability of three antibiotics after intramuscular injection into thigh and buttock.

D. Reeves, R. Wise, V. Whitmarsh, 1974, Lancet.

Chlamydia pneumoniae antibodies in severe essential hypertension.

G. Lip, D. Beevers, G. Lip, 1998, Hypertension.

Pneumococcal infections.

R. Wise, M. Lockley, 1984, British medical journal.

Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.

R. Wise, J. Andrews, J. Stone, 1989, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin

R. Wise, A. Gillett, M. Seddon, 1980, Antimicrobial Agents and Chemotherapy.

InVitro Activity ofBay09867, aNew Quinoline Derivative, Compared withThoseofOtherAntimicrobial Agents

R. Wise, J. Andrews, L. J. Edwards, 1983 .

Antimicrobial resistance: priorities for action.

R. Wise, 2002, The Journal of antimicrobial chemotherapy.

Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach.

R. Wise, I. Donovan, J. Gearty, 1988, The Journal of antimicrobial chemotherapy.

Introduction: treatment of Gram-positive infections.

R. Wise, 2003, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and Inflammatory Fluid Penetration of Intravenous Daptomycin in Volunteers

B. Dvorchik, R. Wise, J. Andrews, 2002, Antimicrobial Agents and Chemotherapy.

Quinolone resistance in Salmonella spp: veterinary pointers

L. Piddock, R. Wise, C. Wray, 1990, The Lancet.

Quinolone resistance in salmonella: clinical experience

L. Piddock, R. Wise, K. Whale, 1990, The Lancet.

Pharmacokinetics and tissue penetration of ciprofloxacin

R. Wise, J. Dent, B. Crump, 1983, Antimicrobial Agents and Chemotherapy.

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

R. Wise, J. Andrews, L. J. Edwards, 1983, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences.

J. Walker, R. Wise, M. Mitchard, 1979, Journal of Antimicrobial Chemotherapy.

The carbapenems and penem antibiotics—a brief review

R. Wise, 1990 .

Review of the in-vitro evaluation of FCE 22101.

R. Ballard, R. Wise, 1989, The Journal of antimicrobial chemotherapy.

In vitro activity of the tricyclic beta-lactam GV104326

R. Wise, J. Andrews, N. Brenwald, 1996, Antimicrobial Agents and Chemotherapy.

In vitro and pharmacokinetic properties of the carbapenems

R. Wise, 1986, Antimicrobial Agents and Chemotherapy.

The in-vitro activity of faropenem, a novel oral penem.

R. Wise, J. Andrews, J. Ashby, 1997, The Journal of antimicrobial chemotherapy.

Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics

R. Wise, J. Andrews, G. Danks, 1983, Antimicrobial Agents and Chemotherapy.

Comparison of In Vitro Activity of FCE 22101, a New Penem, with Those of Other ,-Lactam Antibiotics

R. Wise, J. Andrews, G. Danks, 2022 .

In vitro activity of CGP 31608, a new penem

L. Piddock, R. Wise, J. Andrews, 1987, Antimicrobial Agents and Chemotherapy.

Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem.

R. Wise, J. Andrews, J. Ashby, 2002, The Journal of antimicrobial chemotherapy.

Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effect.

R. Wise, J. Andrews, F. Boswell, 1997, The Journal of antimicrobial chemotherapy.

The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens.

R. Wise, J. Andrews, 1994, The Journal of antimicrobial chemotherapy.

The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC.

R. Wise, J. Andrews, F. Boswell, 1994, The Journal of antimicrobial chemotherapy.

Study to assess the reliability of a disc diffusion method for determining the sensitivity of gram-positive pathogens to dalfopristin/quinupristin.

R. Wise, J. Andrews, J. Ashby, 1999, The Journal of antimicrobial chemotherapy.

Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods.

J. Sunderland, R. Wise, J. Andrews, 1997, The Journal of antimicrobial chemotherapy.

In vitro activity of L-627, a new carbapenem

R. Wise, J. Andrews, C. Catchpole, 1992, Antimicrobial Agents and Chemotherapy.

Antibiotics for the uncommon cold

R. Wise, 1996, The Lancet.

The in-vitro activity of linezolid (U-100766) and tentative breakpoints.

R. Wise, J. Andrews, J. Ashby, 1998, The Journal of antimicrobial chemotherapy.

In-vitro activity of two glycylcyclines against enterococci resistant to other agents.

A. Fraise, R. Wise, J. Andrews, 1995, The Journal of antimicrobial chemotherapy.

Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect.

R. Wise, J. Andrews, F. Boswell, 1998, The Journal of antimicrobial chemotherapy.

Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.

A. Fraise, R. Wise, J. Andrews, 1997, The Journal of antimicrobial chemotherapy.

The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.

R. Wise, J. Andrews, N. Brenwald, 1993, The Journal of antimicrobial chemotherapy.

Norfloxacin--a review of pharmacology and tissue penetration.

R Wise, R. Wise, 1984, The Journal of antimicrobial chemotherapy.

Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.

J. Andrews, D. Honeybourne, S. Hawser, 2007, The Journal of antimicrobial chemotherapy.

Microbiological and Immunological Assays of Antimicrobials

R. Wise, 1985 .

Disc sensitivity testing to ofloxacin.

R. Wise, J. Andrews, Y. Jin, 1990, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and Inflammatory-Fluid Penetration of Moxifloxacin following Oral or Intravenous Administration

G. Hartman, R. Wise, J. Andrews, 1999, Antimicrobial Agents and Chemotherapy.

Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint.

R. Wise, J. Andrews, J. Ashby, 2001, The Journal of antimicrobial chemotherapy.

Identification of an Efflux Pump Gene,pmrA, Associated with Fluoroquinolone Resistance inStreptococcus pneumoniae

R. Wise, M. Gill, N. Brenwald, 1999, Antimicrobial Agents and Chemotherapy.

In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin

R. Wise, J. Andrews, K. Bedford, 1978, Antimicrobial Agents and Chemotherapy.

A Review of its Antibacterial Activity, Pharmacokinetic Properties, Clinical Efficacy and Tolerability in Lower Respiratory Tract Infections

H. Lode, J. Pemán, P. Géhanno, 1997 .

Protein binding of beta-lactams: the effects on activity and pharmacology particularly tissue penetration. I.

R. Wise, 1983, The Journal of antimicrobial chemotherapy.

Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.

A. MacGowan, R. Wise, A. Macgowan, 2001, The Journal of antimicrobial chemotherapy.

The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin.

R. Wise, M. Gill, N. Brenwald, 1997, The Journal of antimicrobial chemotherapy.

Mechanisms of resistance to quinolones and clinical perspectives.

L. Piddock, L. Piddock, R. Wise, 1989, The Journal of antimicrobial chemotherapy.

Comparison of sensititre dried microtitration trays with a standard agar method for determination of minimum inhibitory concentrations of antimicrobial agents

D. Reeves, R. Wise, J. Andrews, 1980, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.

M. Cooper, K. Nye, R. Wise, 1990, The Journal of antimicrobial chemotherapy.

The Clinical Relevance of Protein Binding and Tissue Concentrations in Antimicrobial Therapy

R. Wise, 1986, Clinical pharmacokinetics.

The pharmacokinetics of moxalactam in renal failure.

P. J. Wills, R. Wise, N. Wright, 1981, The Journal of antimicrobial chemotherapy.

Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease

P. J. Wills, R. Wise, N. Wright, 1981, Antimicrobial Agents and Chemotherapy.

Cefoxitin: a hospital study.

A. P. Ball, A. Geddes, R. Wise, 1977, British medical journal.

In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds

R. Wise, J. Andrews, J. Hancox, 1982, Antimicrobial Agents and Chemotherapy.

Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

R. Wise, J. Andrews, K. Bedford, 1980, The Journal of antimicrobial chemotherapy.

N-Formimidoyl-thienamycin a novel β-actam: an in-vitro comparison with other β-lactam antibiotics

R. Wise, J. Andrews, N. Patel, 1981 .

The postantibiotic effect of imipenem.

R. Wise, J. Andrews, N. Manek, 1986, The Journal of antimicrobial chemotherapy.

Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time kill kinetics and postantibiotic effect.

R. Wise, J. Andrews, F. Boswell, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activity of Azlocillin and Mezlocillin Against Gram-Negative Organisms: Comparison with Other Penicillins

R. Wise, J. Andrews, A. Gillett, 1978, Antimicrobial Agents and Chemotherapy.

The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamases.

L. Piddock, R. Wise, J. Ashby, 1987, The Journal of antimicrobial chemotherapy.

Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers.

R. Wise, J. Andrews, R. Brown, 1982, The Journal of antimicrobial chemotherapy.

Newer mechanisms of resistance to β-lactam antibiotics in Gram-negative bacteria

L. Piddock, R. Wise, 1985 .

Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins

P. J. Wills, R. Wise, J. Andrews, 1980, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid

R. Wise, J. Dent, S. Bennett, 1983, Antimicrobial Agents and Chemotherapy.

Newer mechanisms of resistance to beta-lactam antibiotics in gram-negative bacteria.

L. Piddock, R. Wise, 1985, The Journal of antimicrobial chemotherapy.

LY127935, a Novel Oxa-,B-Lactam: an In Vitro Comparison with Other f8-Lactam Antibiotics

R. Wise, J. Andrews, K. Bedford, 2003 .

Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone

R. Wise, J. Ashby, D. Griggs, 1987, Antimicrobial Agents and Chemotherapy.

HR 756, a Highly Active Cephalosporin: Comparison with Cefazolin and Carbenicillin

R. Wise, J. Andrews, M. Logan, 1978, Antimicrobial Agents and Chemotherapy.

Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds

R. Wise, J. Andrews, K. Bedford, 1980, Antimicrobial Agents and Chemotherapy.

Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect

R. Wise, J. Andrews, F. Boswell, 1997, Antimicrobial agents and chemotherapy.

Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations

R. Wise, R. Brown, J. Hancox, 1981, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of rufloxacin in patients with impaired renal function

B. Imbimbo, R. Wise, T. Mant, 1993, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and tissue penetration of cefepime.

K. Nye, R. Wise, J. Andrews, 1989, The Journal of antimicrobial chemotherapy.

SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.

R. Wise, J. Andrews, J. Hancox, 1981, The Journal of antimicrobial chemotherapy.

A study of the relationship between dose and pharmacokinetics of ceftriaxone.

R. Wise, R. Brown, P. Lowe, 1982, The Journal of antimicrobial chemotherapy.

Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.

H. Simmen, W. Siegenthaler, A. Bonetti, 1982, Antimicrobial agents and chemotherapy.

Pharmacokinetics andTissue Penetration ofOrally Administered Lomefloxacin

R. Wise, J. Andrews, J. Ashby, 1988 .

Prevalence of a Putative Efflux Mechanism among Fluoroquinolone-Resistant Clinical Isolates ofStreptococcus pneumoniae

R. Wise, M. Gill, N. Brenwald, 1998, Antimicrobial Agents and Chemotherapy.

The intraperitoneal penetration of temocillin.

R. Wise, J. Drumm, I. Donovan, 1983, The Journal of antimicrobial chemotherapy.

The pharmacology of cefoxitin and the comparison of two human tissue models

R. Wise, D. Thornhill, A. Gillett, 1979 .

Pharmacokinetics and tissue penetration of enoxacin

R. Wise, J. Dent, R. Lockley, 1984, Antimicrobial Agents and Chemotherapy.

A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.

R. Wise, S. Hartley, 1982, The Journal of antimicrobial chemotherapy.

Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration

R. Wise, J. Andrews, R. Brown, 1982, Antimicrobial Agents and Chemotherapy.

NEPHROTOXICITY WITH GENTAMICIN OR TOBRAMYCIN

D. Reeves, A. Emmerson, R. Wise, 1980, The Lancet.

Cross-resistance of nalidixic acid resistantEnterobacteriaceae to new quinolones and other antimicrobials

L. Piddock, R. Wise, J. Diver, 1986, European Journal of Clinical Microbiology.

MRSA bacteraemia.

R. Wise, C. Catchpole, A. Fraise, 1997, The Journal of hospital infection.

Reply by Professor Richard Wise

R. Wise, 1995 .

The pharmacokinetics and tissue penetration of imipenem.

R. Wise, J. Andrews, J. Drumm, 1986, The Journal of antimicrobial chemotherapy.

The development of macrolides and related compounds.

R. Wise, 1989, Journal of Antimicrobial Chemotherapy.

The in-vitro activity of FK-037, a new broad spectrum injectable cephalosporin.

R. Wise, J. Andrews, D. Thornber, 1994, The Journal of antimicrobial chemotherapy.

Intrapulmonary penetration of linezolid.

D. Honeybourne, R. Wise, J. Andrews, 2003, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species

R. Wise, D. Roscoe, A. M. Clarke, 1992, Antimicrobial Agents and Chemotherapy.

Antibiotic resistance--an evolving problem.

E. Soulsby, R. Wise, 2002, The Veterinary record.

In Vitro Activities of Peptide Deformylase Inhibitors against Gram-Positive Pathogens

R. Wise, J. Andrews, J. Ashby, 2002, Antimicrobial Agents and Chemotherapy.

The prevalence of ampicillin, cephalosporin and sulphonamide resistance amongst urinary tract pathogens.

D. Reeves, A. Emmerson, R. Wise, 1975, Scottish medical journal.

The Prevalence of Ampicillin, Cephalosporin and Sulphonamide Resistance Amongst Urinary Tract Pathogens

D. Reeves, A. Emmerson, R. Wise, 1975 .

Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria.

R. Wise, J. Andrews, J. Ashby, 1999, The Journal of antimicrobial chemotherapy.

Nalidixic acid-resistant salmonellae

R. Wise, C. Wray, I. Mclaren, 1990, Veterinary Record.

An overview of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR).

R. Wise, 2007, The Journal of antimicrobial chemotherapy.

Antibiotics for acute infective conjunctivitis in children

R. Wise, 2005, The Lancet.

The penetration of cefoxitin into peritoneal fluid.

R. Wise, N. Ambrose, I. Donovan, 1981, The Journal of antimicrobial chemotherapy.

Mechanism of action of lomefloxacin

L. Piddock, R. Wise, M. C. Hall, 1990, Antimicrobial Agents and Chemotherapy.

A simple isocratic high-pressure liquid chromatographic assay of quinolones in serum.

R. Wise, D. Griggs, 1989, The Journal of antimicrobial chemotherapy.

Outer-membrane proteins pattern and detection of beta-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil.

A. Levin, A. Barone, R. Wise, 2000, International journal of antimicrobial agents.

In vitro activity of fludalanine combined with pentizidone compared with those of other agents

R. Wise, J. Andrews, 1984, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.

R. Wise, Z. Adhami, R. Lockley, 1984, The Journal of antimicrobial chemotherapy.

Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility.

L. Piddock, R. Wise, 1987, The Journal of antimicrobial chemotherapy.

Quorum sensing: potential means of treating gram-negative infections?

G. Hartman, R. Wise, Giles Hartman, 1998, The Lancet.

Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin

M. Cooper, R. Wise, J. Andrews, 1991, Antimicrobial Agents and Chemotherapy.

An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

J. Saunders, D. Nathwani, P. Bennett, 2004, The Journal of antimicrobial chemotherapy.

Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.

D. Honeybourne, R. Wise, J. Andrews, 1995, The Journal of antimicrobial chemotherapy.

The pharmacokinetics of enoxacin in elderly patients.

R. Wise, D. Griggs, S. Baker, 1987, The Journal of antimicrobial chemotherapy.

The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.

T. Ling, A. Cheng, K. Fung, 1993, The Journal of antimicrobial chemotherapy.

Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.

R. Wise, J. Andrews, J. Ashby, 1991, Diagnostic microbiology and infectious disease.

Comparative in vitro microbiological activity and stability of cefaclor.

R. Wise, J. Andrews, A. P. Gillett, 1979, Postgraduate medical journal.

The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?

L. Mandell, L. Peterson, D. Hooper, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

C. Mcnulty, R. Wise, J. Dent, 1985, Antimicrobial Agents and Chemotherapy.

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.

R. Wise, J. Andrews, G. Danks, 1984, The Journal of antimicrobial chemotherapy.

The pharmacokinetics and tissue penetration of ofloxacin.

R. Wise, J. Dent, M. Lockley, 1984, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.

R. Wise, J. Andrews, D. Griggs, 1988, Reviews of infectious diseases.

The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.

K. Nye, R. Wise, J. Andrews, 1989, The Journal of antimicrobial chemotherapy.

In vitro studies of S-25930 and S-25932, two new 4-quinolones

L. Piddock, R. Wise, J. Andrews, 1986, European Journal of Clinical Microbiology.

Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents againstChlamydia trachomatis

R. Wise, J. Andrews, R. Matthews, 1987, European Journal of Clinical Microbiology.

Pharmacokinetics and tissue penetration of orally administered lomefloxacin

R. Wise, J. Andrews, J. Ashby, 1988, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics of the oral cephalosporins--a review.

R. Wise, 1990, The Journal of antimicrobial chemotherapy.

Volunteer and clinical studies with carfecillin: a new orally administered ester of carbenicillin.

D. Reeves, R. Wise, J. Allen, 1975, British medical journal.

The comparative pharmacokinetics of five quinolones.

C. Mcnulty, R. Wise, J. Andrews, 1986, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of intravenously administered ciprofloxacin

R. Wise, J. Dent, R. Lockley, 1984, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics and tissue penetration of norfloxacin.

R. Wise, Z. Adhami, B. Crump, 1984, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.

R. Wise, J. Andrews, J. Ashby, 2001, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and Inflammatory Fluid Penetration of Clinafloxacin

I. Das, R. Wise, J. Andrews, 1998, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219)

D. Mortiboy, R. Wise, J. Andrews, 1996, Antimicrobial agents and chemotherapy.

Pharmacokinetics and inflammatory fluid penetration of sparfloxacin

M. Cooper, R. Wise, J. Andrews, 1992, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.

B. Imbimbo, R. Wise, J. Andrews, 1991, The Journal of antimicrobial chemotherapy.

Penetration of amoxycillin and clavulanic acid into bone.

M. Karpinski, R. Grimer, R. Wise, 1986, Chemotherapy.

Concentrations of temafloxacin in serum and bronchial mucosa

D. Baldwin, D. Honeybourne, R. Wise, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid

D. Mortiboy, A. Chow, R. Wise, 1995, Antimicrobial agents and chemotherapy.

A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens.

I. Phillips, J. Duval, R. Finch, 1996, The Journal of antimicrobial chemotherapy.

Multiple‐dose pharmacokinetics of rufloxacin in patients with cirrhosis

R. Wise, B. Imbimbo, R. Wise, 1993, Hepatology.

The pharmacokinetics of ofloxacin and a review of its tissue penetration.

R. Wise, M. Lockley, 1988, The Journal of antimicrobial chemotherapy.

Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.

M. Cooper, R. Wise, J. Andrews, 1991, The Journal of antimicrobial chemotherapy.

The killing action of fleroxacin upon Bacteroides fragilis.

L. Piddock, R. Wise, D. Griggs, 1989, The Journal of antimicrobial chemotherapy.

Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.

R Wise, A. Fraise, R. Wise, 2004, The Journal of antimicrobial chemotherapy.

In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents

R. Wise, J. Andrews, J. Ashby, 1988, Antimicrobial Agents and Chemotherapy.

Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.

R. Wise, J. Andrews, K. Bedford, 1981, The Journal of antimicrobial chemotherapy.

Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses

R. Wise, J. Andrews, J. Ashby, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Concentrations of oral lomefloxacin in serum and bronchial mucosa

D. Baldwin, D. Honeybourne, R. Wise, 1990, Antimicrobial Agents and Chemotherapy.

In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents

R. Wise, J. Andrews, N. Manek, 1986, Antimicrobial Agents and Chemotherapy.

Cefotaxime in septicaemia including typhoid fever.

R. Bax, A. Geddes, R. Wise, 1980, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing

R. Wise, J. Andrews, J. Ashby, 1987, Antimicrobial Agents and Chemotherapy.

Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.

R. Wise, J. Andrews, F. Boswell, 2001, The Journal of antimicrobial chemotherapy.

The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.

M. J. Hall, D. Reeves, A. Emmerson, 1985, Current medical research and opinion.

Meropenem pharmacokinetics and penetration into an inflammatory exudate

M. Cooper, R. Wise, J. Andrews, 1990, Antimicrobial Agents and Chemotherapy.

Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique.

R Wise, R. Wise, J. Andrews, 2000, The Journal of antimicrobial chemotherapy.

NON-INVASIVE SAMPLING METHOD FOR DETECTING CHLAMYDIA TRACHOMATIS

R. Wise, D. White, R. Matthews, 1989, The Lancet.

ANTIMICROBIAL AGENTS: A WIDENING CHOICE

R. Wise, 1987, The Lancet.

A comparison of three rapid methods for the detection of beta-lactamase activity in Haemophilus influenzae.

R. Wise, A. Skinner, 1977, Journal of clinical pathology.

A comparison between imipenem and metronidazole prophylaxis against sepsis following appendicectomy.

R. Wise, I. Donovan, D. Burkitt, 1990, The Journal of hospital infection.

Metronidazole and Augmentin in the prevention of sepsis after appendicectomy

R. Wise, J. Drumm, I. Donovan, 1985, The British journal of surgery.

Metronidazole and ticarcillin in the prevention of sepsis after appendicectomy.

R. Wise, N. Ambrose, I. Donovan, 1983, American journal of surgery.

The relentless rise of resistance?

R. Wise, 2004, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of Bay k 4999, a New Broad-Spectrum Penicillin

P. Welling, R. Wise, D. Thornhill, 1979, Antimicrobial Agents and Chemotherapy.

PENETRATION OF FOUR CEPHALOSPORINS INTO TISSUE FLUID IN MAN

R. Wise, A. P. Gillett, 1978, The Lancet.

PENICILLINS AND CEPHALOSPORINS: ANTIMICROBIAL AND PHARMACOLOGICAL PROPERTIES

R. Wise, 1982, The Lancet.

STABILITY OF β-LACTAM ANTIBIOTICS CONTAINING N-METHYLYLTHIOTETRAZOLE SIDE-CHAIN

R. Wise, J. Dent, 1983, The Lancet.

Stability of beta-lactam antibiotics containing N-methylthiotetrazole side-chain.

R. Wise, J. Dent, 1983, Lancet.

An outbreak of infection caused by a gentamicin-resistant Staphylococcus aureus.

R. Wise, A. Bint, R. H. George, 1977, Journal of clinical pathology.

Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels

R. Wise, S. Baker, R. Livingston, 1980, Antimicrobial Agents and Chemotherapy.

LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics

R. Wise, J. Andrews, K. Bedford, 1979, Antimicrobial Agents and Chemotherapy.

Antimicrobial resistance: the microbe's struggle for survival.

R. Wise, 2010, Equine veterinary journal.

Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa.

R. Wise, J. Andrews, F. Boswell, 1997, The Journal of antimicrobial chemotherapy.

BACTERICIDAL ACTIVITY OF TROVAFLOXACIN UNDER ANAEROBIC AND AEROBIC CONDITIONS

R. Wise, J. Andrews, F. Boswell, 1996 .

The antibacterial activity of meropenem in combination with gentamicin or vancomycin.

R. Wise, J. Andrews, J. Ashby, 1989, The Journal of antimicrobial chemotherapy.

Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.

C. Mcnulty, R. Wise, J. Andrews, 1986, The Journal of hospital infection.

In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.

M. Cooper, R. Wise, J. Andrews, 1990, The Journal of antimicrobial chemotherapy.

The pharmacokinetics and tissue penetration of teicoplanin.

C. Mcnulty, R. Wise, J. Andrews, 1986, The Journal of antimicrobial chemotherapy.

Intraperitoneal penetration of cefpirome

R. Wise, J. Ashby, I. Donovan, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Intraperitoneal penetration of pefloxacin

R. Wise, J. Ashby, I. Donovan, 1986, European Journal of Clinical Microbiology and Infectious Diseases.

Intraperitoneal penetration of meropenem.

R. Wise, J. Andrews, A. Hextall, 1991, The Journal of antimicrobial chemotherapy.

Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin).

R. Wise, I. Donovan, N. Manek, 1987, The Journal of antimicrobial chemotherapy.

Intraperitoneal penetration of cefotetan

R. Wise, J. Dent, J. Drumm, 1983, Antimicrobial Agents and Chemotherapy.

Penetration of sulbactam and ampicillin into peritoneal fluid

R. Wise, J. Andrews, J. Drumm, 1983, Antimicrobial Agents and Chemotherapy.

The penetration of amoxycillin/clavulanic acid into peritoneal fluid.

R. Wise, J. Andrews, J. Drumm, 1983, The Journal of antimicrobial chemotherapy.

The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone.

R. Wise, J. Andrews, 1999, The Journal of antimicrobial chemotherapy.

An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.

P. Hawkey, J. Xiong, R. Wise, 2003, Journal of Antimicrobial Chemotherapy.

Susceptibility testing of cefpirome.

R. Wise, J. Andrews, 1992, The Journal of antimicrobial chemotherapy.

A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.

L. Piddock, R. Wise, E. Traynor, 1990, The Journal of antimicrobial chemotherapy.

Sch 29482--a novel penem antibiotic: an in-vitro comparison of its activity with other beta-lactams.

R. Wise, J. Andrews, R. Brown, 1982, Journal of Antimicrobial Chemotherapy.

Ro 13-9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an invitro comparative study.

R. Wise, J. Andrews, K. Bedford, 1980, The Journal of antimicrobial chemotherapy.

Mechanisms of resistance to the carbapenems.

R. Wise, M. Gill, D. Livingstone, 1995, The Journal of antimicrobial chemotherapy.

Macrolide, lincosamide, and streptogramin antibiotics

R. Wise, Niamh OʼSullivan, 1990 .

Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam

C. Mcnulty, R. Wise, J. Ashby, 1985, Antimicrobial Agents and Chemotherapy.

The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.

L. Piddock, R. Wise, J. Andrews, 1985, The Journal of antimicrobial chemotherapy.

The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.

R. Wise, J. Andrews, J. Ashby, 1990, The Journal of antimicrobial chemotherapy.

Use of antibiotics. Penicillins.

R. Wise, 1978, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.

In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites

L. Piddock, R. Wise, J. Andrews, 1986, Antimicrobial Agents and Chemotherapy.

A comparison of the pharmacokinetics of amikacin and gentamicin.

J. Walker, R. Wise, M. Mitchard, 1981, The Journal of antimicrobial chemotherapy.

Induction of the SOS response in Escherichia coli by 4‐quinolone antimicrobial agents

L. Piddock, R. Wise, 1987 .

The in vitro activity of ABT773, a new ketolide antimicrobial agent.

R. Wise, J. Andrews, J. Ashby, 2000, The Journal of antimicrobial chemotherapy.

β-LACTAMS AND IMIPENEM

R. Wise, J. Ashby, B. Kirkpatrick, 1986, The Lancet.

Cefotetan elimination in patients with varying degrees of renal dysfunction.

R. Wise, T. Hegarty, N. Wright, 1983, The Journal of antimicrobial chemotherapy.

In vitro activity of a catechol-substituted cephalosporin, GR69153

R. Wise, J. Andrews, J. Ashby, 1991, Antimicrobial Agents and Chemotherapy.

In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents

R. Wise, J. Andrews, J. Ashby, 1990, Antimicrobial Agents and Chemotherapy.

InVitro Activity ofBayv 3522, a NewCephalosporin, Compared withActivities ofOtherAgents

R. Wise, J. Andrews, J. Ashby, 1990 .

Molecular and Kinetic Comparison of the Novel Extended-Spectrum β-Lactamases CTX-M-25 and CTX-M-26

Mark A. Miller, M. Mulvey, D. Boyd, 2004, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.

P. Welling, M. Kendall, A. Selen, 1979, International journal of clinical pharmacology and biopharmacy.

Activity of mezlocillin against gram-negative and gram-positive organisms: comparison with other penicillins.

R. Wise, J. Andrews, 1982, The Journal of antimicrobial chemotherapy.

Chlamydia trachomatis in male urine samples . and confirmatory test for the detection of Evaluation of an enzyme-linked immunoassay

K. Radcliffe, R. Wise, R. Matthews, 2005 .

Evaluation of an enzyme-linked immunoassay and confirmatory test for the detection of Chlamydia trachomatis in male urine samples.

K. Radcliffe, R. Wise, R. Matthews, 1993, Genitourinary medicine.

Science, medicine, and the future

R. Wise, 1998 .

In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing method.

R. Wise, J. Andrews, 2001, The Journal of antimicrobial chemotherapy.

A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998.

J. Andrews, R. Wise, J. Ashby, 2000, The Journal of antimicrobial chemotherapy.

Azlocillin and mezlocillin, two new alpha-amino-substituted penicillins. A comparison of the in vitro activity with other penicillins.

R. Wise, 1979, Arzneimittel-Forschung.

Methods for Evaluating the Penetration of β-Lactam Antibiotics into Tissues

R. Wise, 1986 .

RATIONAL CHOICE OF ANTIBIOTIC

R. Wise, S. Selwyn, 1976, The Lancet.

A review of the mechanisms of action and resistance of antimicrobial agents.

R. Wise, 1999, Canadian respiratory journal.

MINIREVIEWS Pulmonary Disposition ofAntimicrobial Agents: Methodological Considerations

D. Baldwin, D. Honeybourne, R. Wise, 1992 .

Sterile pyuria and Chlamydia trachomatis

R. Wise, R. Matthews, S. Bonigal, 1990, The Lancet.

In vitro susceptibility of Neisseria meningitidis.

R. Wise, J. Andrews, 2000, The Journal of antimicrobial chemotherapy.

A pharmacological and in vitro comparison of three oral cephalosporins.

P. Welling, M. Kendall, R. Wise, 1979, The Journal of antimicrobial chemotherapy.

Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.

D. Reeves, R. Wise, 1974, Chemotherapy.

Raised urinary neopterin levels and Chlamydia trachomatis infection.

R. Wise, R. Matthews, J. Woodcock, 1994, The Journal of infection.

The in vitro activity of BMS-284756, a new des-fluorinated quinolone.

R. Wise, J. Andrews, G. Jevons, 2002, The Journal of antimicrobial chemotherapy.

The disposition of sodium fusidate in man.

R. Wise, M. Mitchard, M. Pippard, 1977, British journal of clinical pharmacology.

Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.

R. Wise, J. Diver, 1986, The Journal of antimicrobial chemotherapy.

Single-Dose Pharmacokinetics and Penetration of BMS 284756 into an Inflammatory Exudate

R. Wise, J. Andrews, T. Gee, 2002, Antimicrobial Agents and Chemotherapy.

In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.

I. Gould, R. Wise, J. Dent, 1987, The Journal of antimicrobial chemotherapy.

The mode of action of Sch 34343: affinity for the penicillin binding proteins of Escherichia coli K-12 and Bacteroides fragilis.

L. Piddock, R. Wise, 1985, The Journal of antimicrobial chemotherapy.

The need for new antibiotics

L. Piddock, R. Wise, 2010, The Lancet.

Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.

D. Baldwin, D. Honeybourne, R. Wise, 1990, Journal of Antimicrobial Chemotherapy.

CLAVULANIC ACID AND SUSCEPTIBILITY OF BACTEROIDES FRAGILIS TO PENICILLIN

R. Wise, 1977, The Lancet.

An investigation of the hydrophobicity of the quinolones.

L. Piddock, R. Wise, J. Ashby, 1986, The Journal of antimicrobial chemotherapy.

The effect of altered porin expression in Escherichia coli upon susceptibility to 4-quinolones.

L. Piddock, R. Wise, 1986, The Journal of antimicrobial chemotherapy.

The bactericidal activity of gatifloxacin in plasma and urine.

R. Wise, J. Andrews, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

CLINDAMYCIN AND PSEUDOMEMBRANOUS COLITIS

R. Wise, A. Tudway, D. Pelta, 1974 .

Comparative microbiological activity and pharmacokinetics of cefprozil

R. Wise, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Avoparcin and animal feedstuff

R. Wise, 1996, The Lancet.

RAPID DIAGNOSIS OF CAMPYLOBACTER PYLORIDIS GASTRITIS

C. Mcnulty, R. Wise, 1986, The Lancet.

Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.

D. Gajjar, A. Bello, D. Honeybourne, 2003, The Journal of antimicrobial chemotherapy.

Is Chlamydia pneumoniae Infection Associated with Acute Cardiac Ischaemic Syndromes

D. Beevers, D. Honeybourne, R. Wise, 1996 .

The selection and frequency of streptococci with decreased susceptibility to ofloxacin compared with other quinolones.

L. Piddock, R. Wise, 1988, The Journal of antimicrobial chemotherapy.

Clinical Pharmacokinetics of Spiramycin

R. Wise, 1993 .

Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.

R. Wise, J. Andrews, J. Ashby, 1988, The Journal of antimicrobial chemotherapy.

A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin.

R. Wise, J. Andrews, J. Webberley, 1988, The Journal of antimicrobial chemotherapy.

Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.

R. Wise, 1991, The American journal of medicine.

The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia.

R. Wise, 1993, The Journal of antimicrobial chemotherapy.

β-Lactamase inhibitors

R. Wise, 1982 .

Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action.

R. Wise, J. Andrews, J. Ashby, 1990, Journal of Antimicrobial Chemotherapy.

Tissue penetration and metabolism of ciprofloxacin.

R. Wise, I. Donovan, 1987, The American journal of medicine.

A survey of susceptibility testing of anaerobes in the United Kingdom.

R. Wise, J. Andrews, 2002, The Journal of antimicrobial chemotherapy.

Antimicrobial resistance: paradox, actions and economics.

R. Wise, 2006, The Journal of antimicrobial chemotherapy.

The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.

R. Wise, J. Andrews, A. P. Gillett, 1979, Journal of Antimicrobial Chemotherapy.

The relevance of pharmacokinetics to in-vitro models: protein binding--does it matter?

R. Wise, 1985, The Journal of antimicrobial chemotherapy.

The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.

R. Wise, J. Andrews, F. Boswell, 1997, The Journal of antimicrobial chemotherapy.

Methods for evaluating the penetration of beta-lactam antibiotics into tissues.

R. Wise, 1986, Reviews of infectious diseases.

Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance.

R. Wise, J. Andrews, G. Jevons, 2002, The Journal of antimicrobial chemotherapy.

Grepafloxacin vs Pneumococci Resistant to Fluoroquinolones by a Putative Efflux Mechanism

R. Wise, M. Gill, N. Brenwald, 1999, Drugs.

Antimicrobial resistance potential

R. Wise, 2001, The Lancet.

A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomy.

R. Wise, J. Drumm, I. Donovan, 1985, The Journal of hospital infection.

Pharmacokinetics and Tissue Penetration of Temocillin

R. Wise, R. Brown, M. Lockley, 2012, Drugs.

Concentrations ofOralLomefloxacin inSerum andBronchial Mucosa

D. Baldwin, D. Honeybourne, M. Andrews, 1990 .

Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.

A. MacGowan, D. Reeves, R. Wise, 1989, The Journal of antimicrobial chemotherapy.

Human pharmacokinetics of ceftazidime in comparison to moxalactam and cefotaxime—abstract

H. Simmen, W. Siegenthaler, A. Bonetti, 1981 .

CIPROFLOXACIN PENETRATION INTO LUNGS

D. Honeybourne, R. Wise, J. Andrews, 1987, The Lancet.

The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction

R. Wise, N. Wright, 2005, Infection.

Pharmacokinetics and tissue penetration of azthreonam

R. Wise, J. Andrews, A. Hegarty, 1982, Antimicrobial Agents and Chemotherapy.

A comparison of the homogeneous enzyme immunoassay and polarization fluoroimmunoassay of gentamicin.

R. Wise, J. Andrews, 1984, The Journal of antimicrobial chemotherapy.

In-vitro activity of PD 131628, a new quinolone antimicrobial agent.

M. Cooper, R. Wise, J. Andrews, 1992, The Journal of antimicrobial chemotherapy.

The effect of mutations in the SOS response on the kinetics of quinolone killing.

R. N. Walters, L. Piddock, R. Wise, 1989, The Journal of antimicrobial chemotherapy.

Protein binding of beta-lactams: the effects on activity and pharmacology particularly tissue penetration. II. Studies in man.

R. Wise, 1983, The Journal of antimicrobial chemotherapy.

Lack of homogeneity of bladder urine.

N. Blacklock, D. Reeves, R. Wise, 1974, The Lancet.

A Clinical Investigation of Pivmecillinam

D. Reeves, R. Wise, J. Symonds, 1976 .

In Vitro Activity of MF 5137, a New Potent 6-Aminoquinolone

O. Tabarrini, V. Cecchetti, A. Fravolini, 2012, Drugs.

Administration of Ticarcillin, a New Antipseudomonal Antibiotic, in Patients Undergoing Dialysis

A. Parker, D. Reeves, R. Wise, 1974, Antimicrobial Agents and Chemotherapy.

The activity of grepafloxacin against respiratory pathogens in the UK.

R. Wise, J. Andrews, 1997, The Journal of antimicrobial chemotherapy.

Nasopharyngeal carriage of Streptococcus pneumoniae: a review of the potential role of pharmacokinetics and pharmacodynamics.

R. Wise, 2002, The Journal of antimicrobial chemotherapy.

The Activity of Mecillinam (FL1060), in Combination with Other Antibiotics, Against H. Influenzae and Streptococcus Faecalis

G. Ayliffe, R. Wise, J. Andrews, 1976 .

Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint.

R. Wise, J. Andrews, J. Ashby, 2001, Journal of Antimicrobial Chemotherapy.

For and against carfecillin--a matter of resistance?

R. Wise, 1975, The Journal of antimicrobial chemotherapy.

Beta-lactams and imipenem.

R. Wise, J. Ashby, B. Kirkpatrick, 1986, Lancet.

Anaerobic infections and their treatment

R. Wise, M. Logan, 1980 .

Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

D. Honeybourne, R. Wise, J. Ashby, 1990, Thorax.

Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniques.

J. Sunderland, D. Honeybourne, R. Wise, 1995, Journal of bioluminescence and chemiluminescence.